Knight Therapeutics, Inc. (GUD.TO)
8.19
+0.24
(+3.02%)
CAD |
TSX |
May 29, 16:00
Knight Therapeutics Shareholders Equity (Quarterly) : 787.27M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 81.74M |
| Bausch Health Cos., Inc. | -2.873B |
| Cipher Pharmaceuticals, Inc. | 185.25M |
| BioSyent, Inc. | 44.99M |
| Revive Therapeutics Ltd. | -3.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.087B |
| Total Liabilities (Quarterly) | 299.33M |
| Debt to Equity Ratio | 0.0886 |
| Current Ratio | 2.322 |
| Net Debt Paydown Yield | -0.56% |